0001310488 2026-01-01 2026-06-30 0001310488 2026-08-10 0001310488 2026-06-30 0001310488 2025-12-31 0001310488 2026-04-01 2026-06-30 0001310488 2025-04-01 2025-06-30 0001310488 2025-01-01 2025-06-30 0001310488 2024-12-31 0001310488 2025-06-30 0001310488 us-gaap:CommonStockMember 2024-12-31 0001310488 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001310488 bfnh:StockPayableMember 2024-12-31 0001310488 us-gaap:RetainedEarningsMember 2024-12-31 0001310488 us-gaap:CommonStockMember 2025-03-31 0001310488 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001310488 bfnh:StockPayableMember 2025-03-31 0001310488 us-gaap:RetainedEarningsMember 2025-03-31 0001310488 2025-03-31 0001310488 us-gaap:CommonStockMember 2025-12-31 0001310488 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001310488 bfnh:StockPayableMember 2025-12-31 0001310488 us-gaap:RetainedEarningsMember 2025-12-31 0001310488 us-gaap:CommonStockMember 2026-03-31 0001310488 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001310488 bfnh:StockPayableMember 2026-03-31 0001310488 us-gaap:RetainedEarningsMember 2026-03-31 0001310488 2026-03-31 0001310488 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001310488 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001310488 bfnh:StockPayableMember 2025-01-01 2025-03-31 0001310488 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001310488 2025-01-01 2025-03-31 0001310488 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001310488 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001310488 bfnh:StockPayableMember 2025-04-01 2025-06-30 0001310488 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001310488 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001310488 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001310488 bfnh:StockPayableMember 2026-01-01 2026-03-31 0001310488 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001310488 2026-01-01 2026-03-31 0001310488 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001310488 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001310488 bfnh:StockPayableMember 2026-04-01 2026-06-30 0001310488 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001310488 us-gaap:CommonStockMember 2025-06-30 0001310488 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001310488 bfnh:StockPayableMember 2025-06-30 0001310488 us-gaap:RetainedEarningsMember 2025-06-30 0001310488 us-gaap:CommonStockMember 2026-06-30 0001310488 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001310488 bfnh:StockPayableMember 2026-06-30 0001310488 us-gaap:RetainedEarningsMember 2026-06-30 0001310488 2020-05-01 2020-05-06 0001310488 bfnh:MrMerleMember 2025-01-01 2025-06-30 0001310488 bfnh:RichardKaiserMember 2025-06-30 0001310488 bfnh:MrFergusonMember 2025-01-01 2025-12-31 0001310488 bfnh:MrAhamdMember 2025-01-01 2025-12-31 0001310488 2026-04-01 2026-04-16 0001310488 bfnh:StockholderMember 2025-05-01 2025-05-18 0001310488 bfnh:BoardOfDirectorsMember 2025-04-01 2025-04-21 0001310488 us-gaap:SeriesAPreferredStockMember 2026-06-30 0001310488 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001310488 2025-01-02 2025-01-24 0001310488 2025-01-02 2025-01-27 0001310488 bfnh:MrMerleFergusonMember 2026-04-01 2026-04-15 0001310488 bfnh:MrMerleFergusonMember 2026-04-01 2026-04-17 iso4217:USD shares iso4217:USD shares pure false Q2 2026 --12-31 0001310488

10-Q true 2026-06-30 false 000-51074 BIOFORCE NANOSCIENCES HOLDINGS, INC. NV 74-3078125 2020 General Booth Blvd Unit 230 Virginia Beach VA 23454 757 306-6090 Yes Yes Yes Non-accelerated Filer false true false 33549005

307

786

2153243

2153550

786

234525 786

2388075

786

12284

11836

21750

506203

50733 101290

84767

619329

84767

619329

0.001

900000000

33549005

33521755

33549

33522

162061305

161760052

2484300

-162275846

-162412117

2303308

-618543

2388075

786

143750

105750

249500

211500

118580

17031

130563

44738

262330

122781

380063

256238

-262330

-122781

-380063

-256238

502373 502373 15322 1361 1361 802000

501012

516334

-802000

238682

-122781

136271

-1058238

33544161

33521755

33532896

32887777

0.01

-0.00

0.00

-0.03

136271

-1058238

155000 502373 2895 68750 1000 7485 22917 1361 802000

3342

1630

89250

211500

-19892

-43108

2000

17413

43151

19413

43151

-479

786

862

307

905

29271755

29272

158789302

-161120166

-2301592

4250000 4250 2970750 2975000

-934650

33521755

33522

161760052

-162054816

-261242

-122781

33521755

33522

161760052

-162177597

-384023

33521755

33522

161760052

-162412117

-618543

-102411

33521755

33522

161760052

-162514528

-720954

2000 2000 286920 286920 27250 27 12333 12360 2200000 2200000 284300 284300

238682

33549005

33549

162061305

2484300

-162275846

2303308

NOTE 1 – Organization & Description of Business The Company was incorporated in the State of Nevada on December 10, 1999 as Silver River Ventures, Inc. On February 24, 2006, the Company completed the acquisition of BioForce Nanosciences Holdings Inc. (“BioForce”), a Delaware corporation, and changed the corporate name at that time. On May 6, 2020, the Company purchased 100,000 shares of Element Acquisition Corporation for $1,000 which then became a wholly owned subsidiary. On October 15, 2020, the Company’s wholly-owned subsidiary changed its name from Element Acquisition Corporation, a Wyoming corporation, to BioForce Nanosciences Holdings, Inc, a Wyoming corporation. On December 14, 2021, the Company’s wholly-owned subsidiary changed its name from BioForce Nanosciences Holdings, Inc., a Wyoming corporation to Element Global Inc., a Wyoming corporation. The Company’s mission is to become a leading provider of vitamin, mineral and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. On June 18, 2026 the Company changed its business operations from the vitamin supplement industry to the oil and gas industry.

100000

1000

NOTE 2 – Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed consolidated balance sheet has been derived from the December 31, 2025 audited financial statements and the unaudited condensed consolidated financial statements as of June 30, 2026 and 2025, have been prepared in accordance with generally accepted accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited financial statements and related footnotes included in our Annual report on Form 10-K for the year ended December 31, 2025 (the “2025 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for fair condensed consolidated financial statements presentation. Operating results for the three and six months ended June 30, 2026, are not necessarily indicative of the results of operations expected for the year ending December 31, 2026. Principles of Consolidation The consolidated financial statements include the accounts of Bioforce Nanosciences Holdings, Inc., and its wholly owned subsidiary, Element Global, Inc., a Wyoming corporation, (the “Company”). All significant inter-company balances have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Earnings (Loss) per Share Earnings (loss) per share of common stock are computed in accordance with FASB ASC 260 “Earnings per Share”. Basic earnings (loss) per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding for each period. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding assuming conversion of all potentially dilutive stock options, warrants and convertible securities, if dilutive. Common stock equivalents that are anti-dilutive are excluded from both diluted weighted average number of common shares outstanding and diluted earnings (loss) per share. Stock-Based Compensation We account for employee and non-employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, Compensation—Stock Compensation, which requires all share-based payments, including grants of stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. Fair Value of Financial Instruments The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximate fair value given their short-term nature or effective interest rates. Revenue Recognition The Company implemented ASC 606, Revenue from Contracts with Customers. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures. The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.

Basis of Presentation The accompanying condensed consolidated balance sheet has been derived from the December 31, 2025 audited financial statements and the unaudited condensed consolidated financial statements as of June 30, 2026 and 2025, have been prepared in accordance with generally accepted accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited financial statements and related footnotes included in our Annual report on Form 10-K for the year ended December 31, 2025 (the “2025 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for fair condensed consolidated financial statements presentation. Operating results for the three and six months ended June 30, 2026, are not necessarily indicative of the results of operations expected for the year ending December 31, 2026.

Principles of Consolidation The consolidated financial statements include the accounts of Bioforce Nanosciences Holdings, Inc., and its wholly owned subsidiary, Element Global, Inc., a Wyoming corporation, (the “Company”). All significant inter-company balances have been eliminated in consolidation.

Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Earnings (Loss) per Share Earnings (loss) per share of common stock are computed in accordance with FASB ASC 260 “Earnings per Share”. Basic earnings (loss) per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding for each period. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding assuming conversion of all potentially dilutive stock options, warrants and convertible securities, if dilutive. Common stock equivalents that are anti-dilutive are excluded from both diluted weighted average number of common shares outstanding and diluted earnings (loss) per share.

Stock-Based Compensation We account for employee and non-employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, Compensation—Stock Compensation, which requires all share-based payments, including grants of stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered.

Fair Value of Financial Instruments The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximate fair value given their short-term nature or effective interest rates.

Revenue Recognition The Company implemented ASC 606, Revenue from Contracts with Customers. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures. The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.

NOTE 3 – Recently Issued Accounting Standards The Company has implemented all new accounting pronouncements that are in effect and is evaluating any that may impact on its financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 4 – Going Concern The Company’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has reported recurring losses from operations and has net current liabilities and an accumulated deficit. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. While the Company is attempting to continue operations and generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management believes that the actions presently being taken to further implement the Company’s business plan; to expand sales with a dynamic marketing campaign and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. During the three and six months ended June 30, 2026 due to the receipt of a legal settlement, the Company was able to pay for its expenses. This allowed the Company to continue as a going concern. Once that settlement is used up in full the Company will have to rely on the officers to pay for all expenses through loans to the Company.

NOTE 5 – Related Party Transactions The Company utilizes the services of Yes International Inc., which is controlled by Mr. Richard Kaiser who is a member of the Board of Directors. Yes International provides all services at no cost except for press release wire services and filing fees. For the three months ended June 30, 2026 and 2025 the Company paid press release wire services and filing fees a total in the amount of $3,388 and $1,780 respectively. For the six months ended June 30, 2026 and 2025 the Company paid press release wire services and filing fees a total in the amount of $3,573 and $1,780 respectively. The Company also currently operates out of Yes International Inc., offices at no cost. During the six months ended June 30, 2025, Mr. Merle Ferguson was issued <span id="xdx_909_eus-gaap--RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c20250101__20250630__srt--CounterpartyNameAxis__custom--MrMerleMember_pdd" title="Restricted Stock, Shares Issued Net of Shares for Tax Withholdings">4,250,000 shares of common stock to reimburse him for accrued compensation and amounts due him totaling $2,173,000. Of this amount Mr. Richard Kaiser allowed Mr. Ferguson to assume $3,386 of his accrued liabilities and $644,023 of his accrued compensation for a total of $647,409. Mr. Ferguson also loaned $51,000 to the Company during the year ended December 31, 2025. During the year ended December 31, 2025, Mr. Ahmad, a shareholder, loaned money to the Company in the amount of $10,000. A formal note was finalized and converted in April 2026. In accordance with the loan document between Mr. Ahmad and the Company, Mr Ahmad was entitled to $11,000 in principal and interest repayment and 3,000 restricted shares as a premium for giving the Company a loan. Mr. Ahmad received 24,250 shares of restricted 144 common stock on April 16, 2026, based on the closing price on that day. The premium of $1,361 is included in the statement of operations as a loss on liability settlement for the three and six months ended June 30, 2026. During the six months ended June 30, 2026 and 2025, two board of directors paid expenses of the Company in the amount of $5,000 and $3,152, respectively. During the six months ended June 30, 2026 $1,527 was repaid to related parties. On April 17, 2026 Mr. Ferguson forgave all amounts due to him including all accrued compensation which amounted to $502,373 and is included in forgiveness of debt for the three and six months ended June 30, 2026. On May 18, 2026, a company related to a stockholder gave the Company $13,000 to assist the Company in paying their bills. On April 21, 2026, a advisor to the board of directors paid a bill on behalf of the Company in the amount of $940. Both of these amounts will be repaid in the future, but no terms have been set. Due to related parties was $50,733 and $101,290 at June 30, 2026 and December 31, 2025, respectively. On May 19, 2026, the board of directors accepted the assignment and lease transfer of eleven (11) Federal Oil and Gas lease assignments from a company related to the majority shareholder of the Company. The value of the land leases are assumed to be the cost basis of the company that gifted them which on May 19, 2026, was $234,525. The Company also received prepaid lease values in the amount of $52,395 on May 19, 2026 which will expire on March 31, 2027. At June 30, 2026, $44,910 of prepaid leases is included in prepaid expenses on the balance sheet. The eleven (11) leases will be subject to annual review for impairment. (See Note 9).

3388 1780 3573 1780

4250000

2173000

3386

644023

647409

51000

10000

In accordance with the loan document between Mr. Ahmad and the Company, Mr Ahmad was entitled to $11,000 in principal and interest repayment and 3,000 restricted shares as a premium for giving the Company a loan. Mr. Ahmad received 24,250 shares of restricted 144 common stock on April 16, 2026, based on the closing price on that day. 1361 1361

5000

3152

1527

502373 502373

13000

940

50733 101290

The value of the land leases are assumed to be the cost basis of the company that gifted them which on May 19, 2026, was $234,525. The Company also received prepaid lease values in the amount of $52,395 on May 19, 2026 which will expire on March 31, 2027.

NOTE 6 – Stock Preferred Stock Preferred stock consists of 100,000,000 shares authorized at $0.001 par value. 10,000,000 of these preferred shares have been separately allocated to Series A Preferred. Preferred stock can be converted into 100 shares of common stock, have dividend rights at 100 times common and have voting rights equal to 100 shares of common stock. At June 30, 2026 and December 31, 2025, there were -0- Series A Preferred shares issued and outstanding. Common Stock Common stock consists of 900,000,000 shares authorized at $0.001 par value. At June 30, 2026 and December 31, 2025, there were 33,549,005 shares issued and outstanding. On January 24, 2025 the Board approved the issuance of 4,250,000 shares of common stock to pay Mr. Ferguson for $2,173,000 that was owed to him. On January 27, 2025 when the stock was issued, the market value per share was $0.70 or $2,975,000. The difference of $802,000 is considered a loss on liability settlement and is included in the statement of operations for the six months ended June 30, 2025.

100000000

0.001

Preferred stock can be converted into 100 shares of common stock, have dividend rights at 100 times common and have voting rights equal to 100 shares of common stock.

900000000

0.001

33549005

4250000

On January 27, 2025 when the stock was issued, the market value per share was $0.70 or $2,975,000.

802000

NOTE 7 – Debt Forgiveness On April 15, 2026, Mr. Merle Ferguson, Chairman of the Board of Directors cancelled his month to month contract of $24,000. Mr. Ferguson also forgave all amounts due him related to his accrued compensation agreement and other amounts due him related to funding expenses of the Company as of April 17, 2026 in the amount of $502,373. 24000 502373 NOTE 8 – Stock Payable During May 2026, the Company signed three (3) contracts that are to be paid in restricted shares of the Company. The shares total to be distributed to 2 advisory board members and a legal consultant are for a total of four (4) million shares. All contracts are for three (3) years terminating in May 2029. On May 19, 2026 the Company also approved the issuance of 200,000 restricted shares to Mr. Ferguson as a performance bonus for his service to the Company for the last ten (10) years. The board also approved issuing 316,909 restricted shares to Mr. Kaiser for all accrued compensation through April 2026. All shares are to be issued at the closing price of the Company’s stock on May 19, 2026 which was $0.55. No stock has been issued at June 30, 2026 therefore the total value of stock payable at June 30, 2026 was $2,484,300. Prepaid expenses related to the contracts was $2,108,333 at June 30, 2026. Company also approved the issuance of 200,000 restricted shares to Mr. Ferguson as a performance bonus for his service to the Company for the last ten (10) years. The board also approved issuing 316,909 restricted shares to Mr. Kaiser for all accrued compensation through April 2026. All shares are to be issued at the closing price of the Company’s stock on May 19, 2026 which was $0.55. 2484300

2108333

NOTE 9 – Assignment of Federal Oil and Gas Leases On June 5, 2026, the Company received an assignment of federal oil and gas leases covering approximately 19,957 acres of land located in the White River Valley, Nye County, Nevada (collectively, the "Nevada Leases") from Natural Minerals Trust, LLC, a Delaware limited liability company, which is controlled by Nexus Capital Investments, Inc., the Company's majority shareholder ("Nexus"). The assignment has been approved by the United States Bureau of Land Management ("BLM"). As a result of the approval, the Company now owns these Nevada Leases, giving the Company oil and gas exploration rights to eleven (11) federal oil and gas leases located in the Great Basin and Range in Nye County, Nevada. The Great Basin is a foreland basin, and its producing formations are mostly from the Devonian and Mississippian Ages. Chainman Shale Formation is the main source rock (up to 9% TOC – Total Organic Carbon) and has good thermal generation windows following depositional episodes that filled the White River Valley with multiple structural traps. The leases target prospective hydrocarbon-bearing formations, including but not limited to the Chainman Shale Formation, Pilot Shale, Ely Limestone Formation, Guilmete Dolomite Formation, Simonson Dolomite Formation and Joana Limestone Formation. These formations have demonstrated commercial oil and gas production in analogous wells operated by third parties in the immediate vicinity of the Nevada Leases. The Nevada Leases have primary terms ranging from 10 years, with automatic extensions (“held by production”) for as long as oil or gas is produced in paying quantities. The Company will be obligated to pay the United States federal government a royalty of 12.5% of gross production revenues, in accordance with standard BLM lease terms. However, no proven reserves have been established, and no pilot wells have been drilled. Accordingly, there is no assurance that we will be able to develop productive oil and gas operations from the land covered by these Nevada Leases.

P10Y

0.125

NOTE 10 – Subsequent Events In accordance with ASC 855-10, the Company has analyzed its operations subsequent to June 30, 2026 to the date of August 7, 2026, and has determined that it does not have a material subsequent events to disclose in these financial statements.

false false false false